Phio Pharmaceuticals Corp (PHIO) — Cash Flow-to-Debt Ratio
Phio Pharmaceuticals Corp (PHIO) has a Cash Flow-to-Debt Ratio of -4.21x as of March 2026, meaning its operating cash flow of $-4.00 Million could theoretically repay -4% of its total liabilities ($950.00K) in one year. Explore PHIO long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Phio Pharmaceuticals Corp Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Phio Pharmaceuticals Corp across 15 annual periods. Also explore PHIO total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Phio Pharmaceuticals Corp (2011–2025)
Year-by-year debt coverage analysis for Phio Pharmaceuticals Corp. For market capitalisation and broader financial context, see how much is Phio Pharmaceuticals Corp worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.95x | $-7.98 Million | $1.34 Million | ▲ +15.0% |
| 2024 | -7.01x | $-7.11 Million | $1.01 Million | ▼ -6.5% |
| 2023 | -6.58x | $-10.75 Million | $1.63 Million | ▼ -7.1% |
| 2022 | -6.14x | $-12.13 Million | $1.97 Million | ▼ -67.8% |
| 2021 | -3.66x | $-11.86 Million | $3.24 Million | ▼ -13.3% |
| 2020 | -3.23x | $-8.80 Million | $2.72 Million | ▲ +14.3% |
| 2019 | -3.77x | $-8.64 Million | $2.29 Million | ▲ +12.5% |
| 2018 | -4.31x | $-7.52 Million | $1.74 Million | ▼ -2.7% |
| 2017 | -4.20x | $-9.51 Million | $2.27 Million | ▼ -37.6% |
| 2016 | -3.05x | $-7.76 Million | $2.54 Million | ▲ +5.3% |
| 2015 | -3.22x | $-7.32 Million | $2.27 Million | ▼ -167.9% |
| 2014 | -1.20x | $-7.76 Million | $6.44 Million | ▼ -90.7% |
| 2013 | -0.63x | $-6.31 Million | $10.00 Million | ▼ -42.6% |
| 2012 | -0.44x | $-5.06 Million | $11.43 Million | ▲ +89.9% |
| 2011 | -4.38x | $-9.99 Million | $2.28 Million | — |